Deltex Medical, Inc.   Report issue

For profit Phase 3
Founded: Chichester United Kingdom (1983)
Status: Left NME R&D (2007)

Organization Overview

First Clinical Trial
2007
NCT00467922
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

hydroxyethyl starch (voluven) (1 trial)

ringer's lactate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis, Ulcerative (Phase 3)

Crohn Disease (Phase 3)

Diverticulitis (Phase 3)

Polyps (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2